Try our Advanced Search for more refined results
Securities
Securities Law360 provides breaking news and analysis on securities law and corporate governance. Coverage includes high-stakes shareholder litigation, government enforcement actions, and related policy developments.
Sign up for a 7-day FREE trial today!
Latest News in Securities
-
January 24, 2025
Deel Blasts Racketeering Suit Over Alleged Money Laundering
Deel Inc. asked a Florida federal judge to permanently end a putative class action alleging it enabled money laundering and facilitated illegal transfers for Surge Capital, which allegedly scammed investors out of $35 million, arguing the plaintiff is trying to pursue liability of "an innocent party for the wrongdoing of another."
-
January 24, 2025
SEC Gets Kraken's Major Questions Doctrine Defense Axed
A California federal judge on Friday partially granted the U.S. Securities and Exchange Commission's bid to ax some of cryptocurrency exchange Kraken's key defenses to allegations it violated securities laws by offering crypto assets without proper registration, saying the case wasn't the type to implicate the so-called major questions doctrine defense.
-
January 24, 2025
Musk Can't Yet Appeal Twitter Investors' Cert., 9th Circ. Says
The Ninth Circuit on Friday rebuffed Elon Musk's request to immediately appeal a California federal judge's decision to certify a class of thousands of Twitter investors over claims the billionaire businessman fraudulently tweeted about the social media company's alleged bot problem to get out of his $44 billion acquisition.
-
January 24, 2025
Trump Media Says Presidential Shield Deflects Investors' Suit
President Donald Trump's social media company on Friday urged the Delaware Chancery Court to dismiss, or at least stay, a lawsuit brought by investors alleging that plans to take the platform public would cheat them out of their shares, arguing that a sitting president is shielded from civil litigation in state court.
-
January 24, 2025
Del. Justices Reject Investor Suit Over Dropped Drug Prospect
Delaware's Supreme Court on Friday upheld a Court of Chancery decision dismissing a Ception Therapeutics Inc. stockholder suit alleging breaches of an agreement to use commercially reasonable efforts before Cephalon Inc., which acquired Ception, and Teva Pharmaceuticals USA Inc. abandoned a new drug prospect.
Areas of Coverage
- AGENCIES
- U.S. Securities and Exchange Commission
- U.S. Commodity Futures Trading Commission
- U.S. Department of Justice
- Self-regulatory organizations
- State and international securities regulators
- POLICY & REGULATION
- Dodd-Frank Act
- Employee Retirement Income Security Act
- Investment Advisers Act
- Investment Company Act
- Private Securities Litigation Reform Act
- Foreign Corrupt Practices Act
- Sarbanes-Oxley Act
- Securities Act
- Securities Exchange Act
- Securities Investor Protection Act
- International banking legislation and regulation
- ENFORCEMENT
- Fraud investigations
- Insider trading charges
- LITIGATION
- Accounting and securities fraud suits
- Shareholder class actions, including derivative suits
- Suits over mortgage-backed securities, credit-default swaps, and other high-risk assets
- Proxy battles and hostile takeover suits
- Securities disputes in bankruptcy cases
- ERISA suits
- PROFILES
- Personnel moves
- Profiles of securities practices
Readership
- Securities and white collar lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals